PubRank

Joseph K Lim

Author PubWeight™ 29.55‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Management and treatment of patients with cirrhosis and portal hypertension: recommendations from the Department of Veterans Affairs Hepatitis C Resource Center Program and the National Hepatitis C Program. Am J Gastroenterol 2009 2.42
2 Daclatasvir for previously untreated chronic hepatitis C genotype-1 infection: a randomised, parallel-group, double-blind, placebo-controlled, dose-finding, phase 2a trial. Lancet Infect Dis 2012 2.41
3 Association of AKI with mortality and complications in hospitalized patients with cirrhosis. Hepatology 2012 2.01
4 Validity of diagnostic codes and liver-related laboratory abnormalities to identify hepatic decompensation events in the Veterans Aging Cohort Study. Pharmacoepidemiol Drug Saf 2011 1.76
5 Hepatic decompensation in antiretroviral-treated patients co-infected with HIV and hepatitis C virus compared with hepatitis C virus-monoinfected patients: a cohort study. Ann Intern Med 2014 1.64
6 Emerging trends in hepatocellular carcinoma incidence and mortality. Hepatology 2014 1.58
7 Use of endoclips in the treatment of massive colonic diverticular bleeding. Gastrointest Endosc 2004 1.25
8 Keratins as susceptibility genes for end-stage liver disease. Gastroenterology 2005 1.24
9 The blood transcriptional signature of chronic hepatitis C virus is consistent with an ongoing interferon-mediated antiviral response. J Interferon Cytokine Res 2012 1.12
10 A phase 2, randomized, double-blind, placebo-controlled study of GS-9450 in subjects with nonalcoholic steatohepatitis. Hepatology 2011 1.12
11 Restoring a gastroenterology fellowship match: a trainee perspective. Am J Gastroenterol 2004 1.07
12 Transient elastography for diagnosis of portal hypertension in liver cirrhosis: is there still a role for hepatic venous pressure gradient measurement? Hepatology 2007 1.06
13 Antiretroviral therapy reduces the rate of hepatic decompensation among HIV- and hepatitis C virus-coinfected veterans. Clin Infect Dis 2013 1.00
14 FIB-4 index is associated with hepatocellular carcinoma risk in HIV-infected patients. Cancer Epidemiol Biomarkers Prev 2011 1.00
15 Developing a modified directly observed therapy intervention for hepatitis C treatment in a methadone maintenance program: implications for program replication. Am J Drug Alcohol Abuse 2012 0.92
16 Graduate medical education research in the 21st century and JAMA on call. JAMA 2004 0.83
17 Liver disease from asymptomatic constrictive pericarditis. J Clin Gastroenterol 2008 0.83
18 Advances in interferon-free hepatitis C therapy: 2014 and beyond. Hepatology 2014 0.82
19 Impact of insulin-sensitizing agents on risk for liver cancer and liver-related death in diabetic patients with compensated hepatitis C cirrhosis. J Clin Endocrinol Metab 2011 0.80
20 Management of chronic hepatitis C infection in children. Curr Opin Pediatr 2012 0.80
21 Persistent racial disparities in survival among u.s. Adults with hepatocellular carcinoma after liver transplantation: the paradox of all-cause and cause-specific mortality. Gastrointest Cancer Res 2013 0.78
22 Vasoconstrictor therapy for the hepatorenal syndrome. Gastroenterology 2008 0.75
23 Impact of rapid point-of-care screening tests for the identification of chronic hepatitis C infection. Hepatology 2013 0.75
24 Isolated Hepatitis B Core Antibody is Associated With Advanced Hepatic Fibrosis in HIV/HCV Infection But Not in HIV Infection Alone. J Acquir Immune Defic Syndr 2016 0.75
25 Child-Turcotte-Pugh Class is Best at Stratifying Risk in Variceal Hemorrhage: Analysis of a US Multicenter Prospective Study. J Clin Gastroenterol 2016 0.75
26 Suicide among u.s. Adults with hepatocellular carcinoma. Gastrointest Cancer Res 2013 0.75
27 Improving the effectiveness of journal reading in gastroenterology. Gastrointest Endosc 2005 0.75